Evidence Report/technology Assessment
Overview
Evidence Report/technology Assessment is a scientific journal, published since 1999 in English. The journal's country of origin is United States.
Details
Details
Abbr.
Evid Rep Technol Assess (Full Rep)
Start
1999
End
2016
p-ISSN
1530-4396
Country
United States
Language
English
Recent Articles
1.
Newberry S, Chung M, Shekelle P, Suttorp Booth M, Liu J, Maher A, et al.
Evid Rep Technol Assess (Full Rep)
. 2018 Oct;
(217):1-929.
PMID: 30313003
Background: In 2009, the Institute of Medicine/Food and Nutrition Board constituted a Dietary Reference Intakes (DRI) committee to undertake a review of the evidence that had emerged (since the 1997...
2.
McDonagh M, Matthews A, Phillipi C, Romm J, Peterson K, Thakurta S, et al.
Evid Rep Technol Assess (Full Rep)
. 2018 Oct;
(216):1-308.
PMID: 30313002
Objectives: To evaluate the benefits and harms of pharmacological therapy for depression in women during pregnancy or the postpartum period. Data Sources: Cochrane Database of Systematic Reviews, the Cochrane Central...
3.
Smith M, Nelson H, Haney E, Pappas M, Daeges M, Wasson N, et al.
Evid Rep Technol Assess (Full Rep)
. 2018 Oct;
(219):1-433.
PMID: 30313001
Objectives: This systematic review summarizes research on methods of diagnosing myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and benefits and harms of multiple medical and nonmedical treatments. It identifies evidence gaps and...
4.
Chou R, Deyo R, Devine B, Hansen R, Sullivan S, Jarvik J, et al.
Evid Rep Technol Assess (Full Rep)
. 2018 Oct;
(218):1-219.
PMID: 30313000
Objectives: Chronic pain is common and use of long-term opioid therapy for chronic pain has increased dramatically. This report reviews the current evidence on effectiveness and harms of opioid therapy...
5.
Balk E, Adams G, Langberg V, Halladay C, Chung M, Lin L, et al.
Evid Rep Technol Assess (Full Rep)
. 2018 Oct;
(223):1-1252.
PMID: 30307737
Background: The effect and association of omega-3 fatty acids (n-3 FA) intake and biomarker levels with cardiovascular (CV) clinical and intermediate outcomes remains controversial. We update prior Evidence Reports of...
6.
Hersh W, Totten A, Eden K, Devine B, Gorman P, Kassakian S, et al.
Evid Rep Technol Assess (Full Rep)
. 2018 Oct;
(220):1-465.
PMID: 30307736
Objectives: This review sought to systematically review the available literature on health information exchange (HIE), the electronic sharing of clinical information across the boundaries of health care organizations. HIE has...
7.
Newberry S, Chung M, Booth M, Maglione M, Tang A, OHanlon C, et al.
Evid Rep Technol Assess (Full Rep)
. 2018 Oct;
(224):1-826.
PMID: 30307735
Objectives: To update a prior systematic review on the effects of omega-3 fatty acids (n-3 FA) on maternal and child health and to assess the evidence for their effects on,...
8.
Wilcox H, Wissow L, Kharrazi H, Wilson R, Musci R, Zhang A, et al.
Evid Rep Technol Assess (Full Rep)
. 2018 Oct;
(222):1-70.
PMID: 30307734
Objectives: Linking national, State, and community data systems, such as those used for medical service billing, to existing data from suicide prevention efforts could facilitate the assessment of longer term...
9.
Maglione M, Gidengil C, Das L, Raaen L, Smith A, Chari R, et al.
Evid Rep Technol Assess (Full Rep)
. 2018 Sep;
(215):1-740.
PMID: 30257278
Objectives: To conduct a systematic review of the literature on the safety of vaccines recommended for routine immunization of children, adolescents, and adults in the United States as of 2011....
10.
McCormack L, Sheridan S, Lewis M, Boudewyns V, Melvin C, Kistler C, et al.
Evid Rep Technol Assess (Full Rep)
. 2014 Jan;
(213):1-520.
PMID: 24423078
Objectives: This review examined how to best communicate and disseminate evidence, including uncertain evidence, to inform health care decisions. The review focused on three primary objectives--comparing the effectiveness of: (1)...